Eltrombopag is a medicine used to treat low platelet counts in people with chronic immune thrombocytopenia (ITP). It is classified as a thrombopoietin receptor agonist and works by stimulating the production of platelets in the bone marrow. It is taken as a once-daily pill and is usually well-tolerated. Common side effects include nausea, diarrhea, and headache.
Eltrombopag, sold under the brand name Revolade, is a medication used to increase the production of platelets in adults and children with certain conditions. Here's a breakdown of its key features:
Purpose:
- Eltrombopag is primarily used to treat chronic immune thrombocytopenia (ITP), an autoimmune disorder that causes unusually low levels of platelets (blood cells essential for clotting).
- It can also be used in adults with hepatitis C or aplastic anemia (bone marrow failure) who have low platelet counts.
How it Works:
- Eltrombopag belongs to a class of drugs called thrombopoietin receptor agonists.
- Platelets are produced in the bone marrow from cells called megakaryocytes.
- Eltrombopag works by stimulating the production of these megakaryocytes, ultimately leading to an increase in platelet count.
Treatment with Eltrombopag:
- Eltrombopag comes as tablets taken by mouth, typically once daily.
- The exact dosage depends on your individual needs, platelet count, and response to the medication.
- Regular blood tests are needed to monitor platelet levels and adjust the dosage as necessary.
Benefits:
- Eltrombopag can effectively increase platelet counts in people with ITP, reducing the risk of bleeding.
- It may also be helpful for individuals with other conditions who experience low platelet counts.
Important Considerations:
- Eltrombopag is not a cure for ITP or other underlying conditions, but it can help manage the symptoms by raising platelet levels.
- It can cause side effects, including headache, diarrhea, nausea, and fatigue.
- Eltrombopag may not be suitable for everyone and should only be used under the supervision of a doctor.
- There's a possibility of developing liver problems or tumor formation in some patients, requiring close monitoring.
- Eltrombopag can interact with other medications, so it's important to tell your doctor about all medications you're taking.
Overall:
Eltrombopag offers a valuable treatment option for people with ITP and other conditions causing low platelet counts. It can significantly improve quality of life by reducing bleeding risks. However, it's important to be aware of potential side effects and the need for close monitoring by a doctor.